成大生物
(688739)
| 流通市值：82.90亿 | | | 总市值：83.87亿 |
| 流通股本：4.12亿 | | | 总股本：4.16亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,593,446,384.59 | 3,692,359,728.24 | 4,364,733,255.88 | 4,010,183,067.13 |
| 交易性金融资产 | 1,531,360,634.6 | 1,398,940,961.65 | 850,466,243.85 | 1,059,830,646.57 |
| 应收票据及应收账款 | 1,158,196,330.1 | 1,050,141,648.45 | 1,049,238,495.92 | 1,170,186,665.95 |
| 应收账款 | 1,158,196,330.1 | 1,050,141,648.45 | 1,049,238,495.92 | 1,170,186,665.95 |
| 预付款项 | 19,375,452.34 | 21,781,323.83 | 24,145,008.89 | 30,982,973.28 |
| 其他应收款合计 | 1,950,128.6 | 1,885,535.61 | 1,868,996.15 | 1,980,736.56 |
| 存货 | 459,143,670.3 | 472,369,110.66 | 474,393,626.22 | 460,177,712.38 |
| 其他流动资产 | 18,248,343.55 | 84,009,696.58 | 22,162,025.74 | 36,878,856.53 |
| 流动资产合计 | 6,781,720,944.08 | 6,721,488,005.02 | 6,787,007,652.65 | 6,770,220,658.4 |
| 非流动资产: | | | | |
| 长期股权投资 | 33,638,277.91 | 33,552,769.56 | 34,329,291.7 | 55,614,556.36 |
| 其他非流动金融资产 | 160,129,635.22 | 176,806,871.46 | 136,806,871.46 | 71,834,730.98 |
| 固定资产 | 1,443,188,471.31 | 1,443,244,852.85 | 1,438,820,698.69 | 1,403,540,340.02 |
| 在建工程 | 368,559,632.9 | 381,285,881.79 | 427,397,299.39 | 499,886,080.03 |
| 使用权资产 | 7,923,033.15 | 9,148,864.56 | 10,374,695.97 | 11,600,527.38 |
| 无形资产 | 815,367,428.4 | 491,581,909.97 | 182,022,580.29 | 184,109,159.58 |
| 开发支出 | - | 313,126,596.23 | 622,382,943.96 | 674,074,166.72 |
| 长期待摊费用 | 7,634,693.96 | 8,669,258.09 | 9,703,822.22 | 10,738,386.35 |
| 递延所得税资产 | 44,139,018.15 | 36,273,217.41 | 34,162,466.86 | 48,713,280.4 |
| 其他非流动资产 | 33,252,567.56 | 60,372,766.97 | 63,199,588.34 | 72,422,392.29 |
| 非流动资产合计 | 2,913,832,758.56 | 2,954,062,988.89 | 2,959,200,258.88 | 3,032,533,620.11 |
| 资产总计 | 9,695,553,702.64 | 9,675,550,993.91 | 9,746,207,911.53 | 9,802,754,278.51 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 158,969,992.5 | 138,305,835.39 | 172,950,902.57 | 218,300,717.14 |
| 应付账款 | 158,969,992.5 | 138,305,835.39 | 172,950,902.57 | 218,300,717.14 |
| 合同负债 | 984,717.42 | 5,632,646.41 | 1,639,166.12 | 96,330.29 |
| 应付职工薪酬 | 86,877,628.9 | 68,443,546.91 | 112,026,109.02 | 94,322,008.36 |
| 应交税费 | 20,866,869.24 | 16,595,467.1 | 6,999,414.86 | 7,076,776.43 |
| 其他应付款合计 | 3,570,500.96 | 2,848,960.96 | 2,407,360.96 | 2,441,177.76 |
| 应付股利 | 439,500.96 | 427,400.96 | 455,400.96 | 465,900.96 |
| 一年内到期的非流动负债 | 4,707,305.55 | 4,653,030.2 | 4,599,173.96 | 5,055,820.51 |
| 其他流动负债 | 63,458.41 | 15,139.82 | 12,159.96 | - |
| 流动负债合计 | 276,040,472.98 | 236,494,626.79 | 300,634,287.45 | 327,292,830.49 |
| 非流动负债: | | | | |
| 租赁负债 | 2,414,627.1 | 4,829,688.16 | 4,773,727.6 | 7,161,557.81 |
| 预计负债 | 7,733,719.09 | 9,170,377.84 | 11,202,980.36 | 3,066,237.91 |
| 递延收益 | 70,112,138.53 | 72,688,984.02 | 75,272,079.51 | 77,855,175 |
| 递延所得税负债 | 133,570.87 | 113,932.65 | 156,840.01 | 190,292.55 |
| 其他非流动负债 | 4,600 | 2,300 | 9,200 | 7,700 |
| 非流动负债合计 | 80,398,655.59 | 86,805,282.67 | 91,414,827.48 | 88,280,963.27 |
| 负债合计 | 356,439,128.57 | 323,299,909.46 | 392,049,114.93 | 415,573,793.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,450,000 | 416,450,000 | 416,450,000 | 416,450,000 |
| 资本公积 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 |
| 减:库存股 | 169,983,790.31 | 160,784,053.11 | 160,784,053.11 | 160,784,053.11 |
| 盈余公积 | 208,225,000 | 208,225,000 | 208,225,000 | 208,225,000 |
| 未分配利润 | 3,848,249,256.86 | 3,854,186,018.02 | 3,856,093,730.17 | 3,889,115,418.32 |
| 归属于母公司股东权益合计 | 9,337,114,586.09 | 9,352,251,084.45 | 9,354,158,796.6 | 9,387,180,484.75 |
| 少数股东权益 | 1,999,987.98 | - | - | - |
| 股东权益合计 | 9,339,114,574.07 | 9,352,251,084.45 | 9,354,158,796.6 | 9,387,180,484.75 |
| 负债和股东权益合计 | 9,695,553,702.64 | 9,675,550,993.91 | 9,746,207,911.53 | 9,802,754,278.51 |
| 公告日期 | 2026-08-25 | 2026-04-29 | 2026-04-21 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |